Mindaugas Jurgutis Selected Research

Primary Myelofibrosis (Myelosclerosis)

10/2021	Updated results of the placebo-controlled, phase III JAKARTA trial of fedratinib in patients with intermediate-2 or high-risk myelofibrosis.
8/2015	Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mindaugas Jurgutis Research Topics

Disease

2	Splenomegaly 10/2021 - 08/2015
2	Primary Myelofibrosis (Myelosclerosis) 10/2021 - 08/2015
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 10/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 03/2016
1	Polycythemia Vera 08/2015
1	Anemia 08/2015
1	Brain Diseases (Brain Disorder) 08/2015
1	Essential Thrombocythemia 08/2015
1	Trisomy (Trisomies) 06/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2011
1	Burkitt Lymphoma (Burkitt's Lymphoma) 04/2009
1	Leukemia 04/2009
1	Albuminuria 01/2007
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2007
1	Bronchiolitis Obliterans Syndrome 01/2007

Drug/Important Bio-Agent (IBA)

2	fedratinibIBA 10/2021 - 08/2015
2	Methylprednisolone FDA LinkGeneric 06/2011 - 01/2007
1	Janus Kinase InhibitorsIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 03/2016
1	CreatinineIBA 08/2015
1	EnzymesIBA 08/2015
1	Transaminases (Aminotransferases)IBA 08/2015
1	Rituximab (Mabthera)FDA Link 06/2011
1	fludarabineIBA 06/2011
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2007

Therapy/Procedure

1	Therapeutics 08/2015
1	Immunotherapy 04/2009
1	Hematopoietic Stem Cell Transplantation 01/2007
1	Transplantation 01/2007
1	Cell Transplantation 01/2007